REG - JP Morgan Sec LLC Aon PLC - AON plc 8.3

AonAnnouncement

03/02/2021 13:45

RNS Number : 9037N
  
J.P. Morgan Securities LLC
  
03 February 2021
  
 

Ap19
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


J.P. Morgan Securities LLC




Company dealt in


AON plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.01 ordinary shares




Date of dealing


 02 February 2021




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


7,301,656                3.20


2,714,210             1.20




(2) Derivatives (other than options)


2,464,896                1.09


24,871                0.01




(3) Options and agreements to purchase/sell


 


 




Total


9,766,552             4.29


2,739,081             1.21



 
 
 
 
 
 
 



 

 

Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 




 
        Purchase/sale


 
Number of relevant securities


 
Price per unit (USD)
 
 (Note 5)




Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
 
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales


14 
 30 
 59 
 5 
 1 
 11,642 
 7 
 1,500 
 39 
 1 
 50 
 1 
 2 
 121 
 55 
 3 
 2 
 24 
 1 
 24 
 13 
 100 
 1 
 102 
 5 
 42 
 1 
 76 
 2 
 100 
 2 
 11 
 45 
 1 
 1 
 53
 
14 
 2 
 100 
 5 
 68 
 119 
 21 
 360 
 40 
 21 
 8,869 
 90 
 7 
 1,500 
 39 
 38 
 200 
 20 
 1 
 100 
 2 
 3 
 66 
 83 
 17 
 121 
 166 
 12 
 600 
 14 
 50 
 40 
 42 
 6 
 2 
 11 
 1 
 61 
 50


206.6800     USD
209.8100     USD
209.9950     USD
210.0900     USD
210.1600     USD
210.1800     USD
210.2486     USD
210.2937     USD
210.3028     USD
210.5200     USD
210.5400     USD
210.5900     USD
210.6100     USD
210.6330     USD
210.6562     USD
210.6600     USD
210.7500     USD
210.7683     USD
210.7700     USD
210.7913     USD
210.7985     USD
210.8150     USD
210.8200     USD
210.8208     USD
210.8480     USD
210.8500     USD
210.8600     USD
210.8900     USD
210.9200     USD
210.9400     USD
210.9600     USD
210.9991     USD
211.0330     USD
211.0400     USD
211.0500     USD
211.1700     USD
 
206.6800     USD
208.5300     USD
208.5600     USD
209.4300     USD
209.8100     USD
209.9325     USD
209.9650     USD
210.1049     USD
210.1600     USD
210.1700     USD
210.1800     USD
210.2100     USD
210.2486     USD
210.2937     USD
210.3028     USD
210.3300     USD
210.4100     USD
210.4400     USD
210.5000     USD
210.5600     USD
210.5700     USD
210.5800     USD
210.5812     USD
210.5950     USD
210.6088     USD
210.6330     USD
210.6445     USD
210.6467     USD
210.7083     USD
210.7871     USD
210.8100     USD
210.8200     USD
210.8460     USD
210.8917     USD
210.9000     USD
210.9991     USD
211.1600     USD
211.1700     USD
211.3300     USD



 
 
 
 



 
 
 
 
 
 
 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(USD)
(Note 5)




Equity Swap


Long
Long
Long
Long


400 
 39 
 1,100 
 121


209.9240     USD
210.3028     USD
210.4281     USD
210.6330     USD




 
 
 
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price (USD)


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




 


 


 


 


 


 


 




 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 




 
Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.
 
      None
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            No
 




Date of disclosure


 03 February 2021




Contact name


Alwyn Basch




Telephone number


0207 742 7407




If a connected EFM, name of offeree/offeror with which connected


N/A




If a connected EFM, state nature of connection (Note 10)


N/A




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEUPUUCPUPGGWW